Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension in a Patient with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
- Author:
Pil Je KANG
1
;
Jae Won LEE
;
Jeong Won KIM
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine. jwlee@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Pulmonary embolism;
Thromboembolism;
Thromboendarterectomy;
Antiphospholipid syndrome;
Systemic lupus eruthematosus
- MeSH:
Antibodies, Anticardiolipin;
Antiphospholipid Syndrome*;
Endarterectomy*;
Humans;
Hypertension, Pulmonary*;
Lupus Coagulation Inhibitor;
Lupus Erythematosus, Systemic*;
Pulmonary Artery;
Pulmonary Embolism;
Thrombocytopenia;
Thromboembolism;
Thrombosis
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2007;40(12):867-870
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Antiphospholipid syndrome (APS) is defined as venous and/or arterial thromboses, recurrent fetal losses, thrombocytopenia in combination with repeatedly positive tests for the lupus anticoagulant (LAC), and anticardiolipin antibodies (aCL). The pulmonary manifestations in APS are relatively rare. We report a rare case of antiphopholipid syndrome with systemic lupus erythematosus in a patient who presented with pulmonary hypertension secondary to a chronic pulmonary thromboembolism. A bilateral thromboendarterectomy was performed satisfactorily and the incision was extended to the left intrapleural pulmonary artery.
